Caloric restriction reverses hepatic insulin resistance and steatosis in rats with low aerobic capacity

Endocrinology

Volumn 151, Issue 11, 2010, Pages 5157-5164

  Bowman, Thomas A ^a   Ramakrishnan, Sadeesh K ^a   Kaw, Meenakshi ^a   Lee, Sang Jun ^a   Patel, Payal R ^a   Golla, Varun K ^a   Bourey, Raymond E ^a   Haram, Per Magnus ^b,c,d   Koch, Lauren G ^e   Britton, Steven L ^e   Wisløff, Ulrik ^d   Lee, Abraham D ^a   Najjar, Sonia M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; TRIACYLGLYCEROL; GLUCOSE; INSULIN;

AEROBIC CAPACITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; HISTOPATHOLOGY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; FATTY LIVER; FIBROSIS; LIVER; METABOLISM; OBESITY; PATHOLOGY; RANDOMIZATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CALORIC RESTRICTION; FATTY LIVER; FIBROSIS; GLUCOSE; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; OBESITY; OXIDATIVE STRESS; PHYSICAL CONDITIONING, ANIMAL; RANDOM ALLOCATION; RATS;

EID: 78049523857     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0176     Document Type: Article

References (28)

1. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE 2002 Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793-801 (Pubitemid 34987553)
2. Wisløff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al-Share Q, Fernström M, Rezaei K, Lee SJ, Koch LG, Britton SL 2005 Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307:418-420
3. Thyfault JP, Rector RS, Uptergrove GM, Borengasser SJ, Morris EM, Wei Y, Laye MJ, Burant CF, Qi NR, Ridenhour SE, Koch LG, Britton SL, Ibdah JA 2009 Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury. J Physiol 587:1805-1816
4. McClain CJ, Mokshagundam SP, Barve SS, Song Z, Hill DB, Chen T, Deaciuc I 2004 Mechanisms of non-alcoholic steatohepatitis. Alcohol 34:67-79
5. Abdeen MB, Chowdhury NA, Hayden MR, Ibdah JA 2006 Nonalcoholic steatohepatitis and the cardiometabolic syndrome. J Cardiometab Syndr 1:36-40
6. Formisano P, Najjar SM, Gross CN, Philippe N, Oriente F, Kern-Buell CL, Accili D, Gorden P 1995 Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem 270:24073-24077
7. Poy MN, Yang Y, Rezaei K, Fernström MA, Lee AD, Kido Y, Erickson SK, Najjar SM 2002 CEACAM1 regulates insulin clearance in liver. Nat Genet 30:270-276
8. Park SY, Cho YR, Kim HJ, Hong EG, Higashimori T, Lee SJ, Goldberg IJ, Shulman GI, Najjar SM, Kim JK 2006 Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. Am J Physiol Endocrinol Metab 291:E517-E524
9. DeAngelis AM, Heinrich G, Dai T, Bowman TA, Patel PR, Lee SJ, Hong EG, Jung DY, Assmann A, Kulkarni RN, Kim JK, Najjar SM 2008 CEACAM1: a link between insulin and lipid metabolism. Diabetes 57:2296-2303
10. Najjar SM, Yang Y, Fernström MA, Lee SJ, Deangelis AM, Rjaily GA, Al-Share QY, Dai T, Miller TA, Ratnam S, Ruch RJ, Smith S, Lin SH, Beauchemin N, Oyarce AM 2005 Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab 2:43-53
11. The Diabetes Prevention Program 2002 Description of lifestyle intervention. Diabetes Care 25:2165-2171
12. Goldberg RB, Temprosa M, Haffner S, Orchard TJ, Ratner RE, Fowler SE, Mather K, Marcovina S, Saudek C, Matulik MJ, Price D 2009 Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the diabetes prevention program randomized trial by the diabetes prevention program research group. Diabetes Care 32:726-732
13. Haram PM, Kemi OJ, Lee SJ, Bendheim MØ, Al-Share QY, Waldum HL, Gilligan LJ, Koch LG, Britton SL, Najjar SM, Wisløff U 2009 Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacity. Cardiovasc Res 81:723-732
14. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, Carruba MO 2005 Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310:314-317
15. Najjar SM, Philippe N, Suzuki Y, Ignacio GA, Formisano P, Accili D, Taylor SI 1995 Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry 34:9341-9349
16. Lee SJ, Heinrich G, Fedorova L, Al-Share QY, Ledford KJ, Fernstrom MA, McInerney MF, Erickson SK, Gatto-Weis C, Najjar SM 2008 Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice. Gastroenterology 135:2084-2095
17. Morris EM, Whaley-Connell AT, Thyfault JP, Britton SL, Koch LG, Wei Y, Ibdah JA, Sowers JR 2009 Low aerobic capacity and high-fat diet contribute to oxidative stress and IRS-1 degradation in the kidney. Am J Nephrol 30:112-119
18. Assimacopoulos-Jeannet F, Brichard S, Rencurel F, Cusin I, Jeanrenaud B 1995 In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues. Metabolism 44:228-233
19. McCormick KL, Susa JB, Widness JA, Singer DB, Adamsons K, Schwartz R 1979 Chronic hyperinsulinemia in the fetal rhesus monkey: effects on hepatic enzymes active in lipogenesis and carbohydrate metabolism. Diabetes 28:1064-1068
20. Deng X, Cagen LM, Wilcox HG, Park EA, Raghow R, Elam MB 2002 Regulation of the rat SREBP-1c promoter in primary rat hepatocytes. Biochem Biophys Res Commun 290:256-262
21. Srinivasan SR, Frontini MG, Berenson GS 2003 Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: the Bogalusa heart study. Metabolism 52:443-450; discussion 451-443
22. Brown MS, Goldstein JL 2008 Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95-96
23. Haeusler RA, Accili D 2008 The double life of Irs. Cell Metab 8:7-9
24. Fiebig RG, Hollander JM, Ney D, Boileau R, Jeffery E, Ji LL 2002 Training down-regulates fatty acid synthase and body fat in obese Zucker rats. Med Sci Sports Exerc 34:1106-1114
25. Larson-Meyer DE, Newcomer BR, Heilbronn LK, Volaufova J, Smith SR, Alfonso AJ, Lefevre M, Rood JC, Williamson DA, Ravussin E 2008 Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity 16:1355-1362
26. Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA 2009 Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 49:80-86
27. Bigorgne AE, Bouchet-Delbos L, Naveau S, Dagher I, Prévot S, Durand-Gasselin I, Couderc J, Valet P, Emilie D, Perlemuter G 2008 Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice. Gastroenterology 134:1459-1469
28. Sheth SG, Gordon FD, Chopra S 1997 Nonalcoholic steatohepatitis. Ann Intern Med 126:137-145